Quick Takeaways
- Alyeska Investment Group, L.P. filed SCHEDULE 13G for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB).
- Disclosed ownership: 5.8%.
- Date of event: 31 Dec 2025.
Alyeska Investment Group, L.P. - 31 Dec 2025 SCHEDULE 13G Report for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB)
- Filing Manager
- Alyeska Investment Group, L.P.
- Reporting Manager
- Alyeska Investment Group, L.P.
- Symbol
- SPRB
- Shares outstanding
- 1,065,112 shares
- Disclosed Ownership
- 61,670 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 16:52:29 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Alyeska Investment Group, L.P. disclosed 5.8% ownership in Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 16:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 5.8% | 61,670 | 0 | 61,670 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 5.8% | 61,670 | 0 | 61,670 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 5.8% | 61,670 | 0 | 61,670 | Anand Parekh | Anand Parekh | Self |